主页文献库搜索
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-...

Patnaik(A),Appleman(L J),Tolcher(A W),Papa... Ann Oncol 0000-00-00

...PIK3CA, KRAS, BRAF, and PTEN mutational status and PTEN immunohistochemistry. Whole-body [(18)F]-fluorodeoxyglucose posi...

The possible roles of B-cell novel protein-1 (BCNP1) in cellular signalling p...

Patel(Sapan J),Trivedi(Gaurang L),Darie(Co... J Cell Mol Med 0000-00-00

...PIK3CA (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit Alpha), MAPK1 (mitogen-activated protein kinas...

Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Onco...

Fuentes-Pananá(Ezequiel M),Morales-Sánchez... Curr Cancer Drug Targets 0000-00-00

...PIK3CA, ARID1A and BCOR genes, and amplification of 9p24.1 that harbors the genes for the JAK2, PD-L1 and PD-L2 proteins...

A Comparison of Fresh Frozen vs. Formalin-Fixed, Paraffin-Embedded Specimens ...

Lüder Ripoli(Florenza),Mohr(Annika),Conrad... Int J Mol Sci 0000-00-00

...Pik3ca; Mcl1; MAPK3; FOXO3; PTEN; GATA4; PFDN5; HMGB1; MAPK1; BRCA2; BRCA1; HMGA2; and Her2) were analyzed via branched-...

A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Recep...

Han(Ji-Youn),Lee(Ki Hyeong),Kim(Sang-We),M... Cancer Res Treat 0000-00-00

...PIK3CA mutations were detected in the prestudy tumors, and seven T790M mutations were detected in the plasma assay. Thre...

Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.

Masugi(Yohei),Nishihara(Reiko),Yang(Juhong... Gut 0000-00-00

...PIK3CA mutations.,CD274 expression in tumour cells or stromal cells (including immune cells) was detected in 731 (89%) o...

Molecular Insights of Pathways Resulting from Two Common PIK3CA Mutations in ...

Bhat-Nakshatri(Poornima),Goswami(Chirayu P... Cancer Res 0000-00-00

...PIK3CA mutations and/or PI3K hyperactivation, we show that PIK3CA-E545K mutations (found in ∼20% of PIK3CA-mutant breast...

Personalized medicine in a phase I clinical trials program: The M. D. Anderso...

Tsimberidou(A M),Iskander(N G),Hong(D S),W... J Clin Oncol 0000-00-00

...PIK3CA mutation; 19% KRAS; 8% NRAS; 19% BRAF; 3% EGFR; and 2% had a CKIT mutation; 21% had PTEN loss. Results are shown ...

Identification of driver mutations in tumor specimens from 1,000 patients wit...

Kris(M G),Johnson(B E),Kwiatkowski(D J),Ia... J Clin Oncol 0000-00-00

...PIK3CA, AKT1, MEK1, and NRAS using standard multiplexed assays and fluorescence in situ hybridization (FISH) for ALK rea...

Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strat...

Keppler-Noreuil(Kim M),Parker(Victoria E R... Am J Med Genet C Semin Med ... 0000-00-00

...PIK3CA-Related Overgrowth Spectrum, Proteus syndrome, and brain overgrowth conditions. Clinical findings in these disord...

上一页 341 342 343 344 345 346 下一页 345 / 共 346

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com